CA42332-2B - 0x000000000000650A

Healthy Males & Females

Action

* Stipend may pay up to reflected amount.
Start Date: 
March 20, 2025 - 3:00pm
End Date: 
April 6, 2025 - 1:30pm

Study Details

Study Number: CA42332
Group Number: 2B
Study Requirement: Healthy Normal Male and Female
Stipend: up to $5,000.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat an inherited disorder that causes muscle and sensation loss called Charcot-Marie-Tooth disorder.
Route of Administration: Oral
Blood Draws: 23

Study Schedule

Schedule Type: Short stays with returns
Study Length: 6 Night Stay, 1 Return & 1 Phone Call

Screening Dates:

Event Day Event Date
Wednesday 3/19/2025
Thursday 3/20/2025

Doctor Exam Dates:

Event Day Event Date
Wednesday 3/19/2025
Thursday 3/20/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 3/20/2025 3:00:00 PM Wednesday 3/26/2025 10:30:00 AM 8 Lincoln
Return Saturday 3/29/2025 9:30:00 AM Saturday 3/29/2025 10:30:00 AM 8 Lincoln
Phone participant Sunday 4/6/2025 1:30:00 PM 8 Lincoln